Search clinical trials for: Apatinib

Total 539 results

Guangxi Medical University

Unknown

The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma
Shanghai Zhongshan Hospital

Unknown

Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
GUO WEI

Completed

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Osteosarcoma | Metastasis

China
Chinese PLA General Hospital

Unknown

Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)

Gastric Cancer

China
Peking University People's Hospital
Peking University Shougang Hospital; Peking University International Hospital

Completed

Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use

Efficacy | Toxicity

China
Yan Li
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer

Breast Cancer
The Affiliated Hospital of the Chinese Academy...

Unknown

Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

Hepatocellular Carcinoma | Gastric Cancer

China
Shandong Cancer Hospital and Institute

Completed

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

Cervical Cancer | Stomach Cancer | Breast Cancer | Esophageal Cancer | Non-small Cell Lung Cancer | Ovary Cancer | Malignancies

China
Fudan University

Unknown

Apatinib for Advanced Biliary Carcinoma

Biliary Tract Neoplasms

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study To Test The Effect Of Apatinib On P450 Enzymes

Cytochrome P450 Interaction

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)

Carcinoma, Non-Small-Cell Lung

China
Henan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Peking University Cancer Hospital & Institute

Unknown

A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma

Advanced Melanoma

China
Afﬁliated Hospital of North Sichuan Medical College
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)

NSCLC

China
Liqiang Zhong

Unknown

Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer

Colorectal Neoplasms
Zigong No.1 Peoples Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

Lung Cancer
Fujian Cancer Hospital

Unknown

Phase I Study of the Combination of Apatinib and POF

Gastric Adenocarcinoma

China
Fudan University
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib in the Treatment of Metastatic Colorectal Cancer

Colorectal Cancer

China
Hebei Medical University Fourth Hospital

Unknown

Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer

Breast Cancer Metastatic

China
Affiliated Hospital of Hebei University

Unknown

A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases

Non-squamous Non-small Cell Lung Cancer

China
Hebei Medical University Fourth Hospital

Unknown

A Study of Apatinib Plus Radiotherapy and S-1 for Treatment of Refractory or Metastatic Esophageal Squamous Cell Carcinoma

Refractory or Metastatic Esophageal Squamous Cell Carcinoma

China
The People's Hospital of Leshan
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Apatinib Treatment in for Advanced Ovarian Cancer

Ovarian Cancer | Chemotherapeutic Toxicity

China
Tianjin Medical University Cancer Institute and...

Unknown

Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
West China Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Apatinib in Recurrent or Recurrent High-grade Glioma

Glioma
Sichuan Cancer Hospital and Research Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-Small-Cell Lung

China
Henan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma

Malignant Melanoma

China
National Nutrition and Food Technology Institute

Unknown

The Effects of Hesperidin on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

Non Alcoholic Steatohepatitis

Iran, Islamic Republic of
Sichuan Provincial People's Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer

Colorectal Cancer | Neoadjuvant Therapy
Jian Fang
Peking University First Hospital; Peking University Third Hospital; The Second...

Unknown

Apatinib in Advanced Non-squamous，NSCLC

Non-squamous Non-Small Cell Lung Cancer

China
Henan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma

Lung Adenocarcinoma

China
Shanxi Province Cancer Hospital

Unknown

Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer

Brain Metastases
Sichuan Cancer Hospital and Research Institute

Unknown

Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy

Lung Cancer | Extensive-stage Small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Chinese PLA General Hospital

Unknown

A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer

Colorectal Cancer

China
West China Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Lung Cancer | Non Small Cell Lung Cancer | Apatinib | Combination Chemotherapy

China
Anhui Provincial Hospital

Unknown

Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer

Two Different Treatment Methods

China
The First Affiliated Hospital of Anhui Medical...

Unknown

The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui Province

Gastric Cancer

China
Hebei Medical University
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

Gastric Cancer

China
Hebei Medical University
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

Gastric Cancer

China
Xiayun He, MD

Unknown

Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer

Thyroid Cancer

China
Elevar Therapeutics
Bukwang Pharmaceutical, Co., Ltd.

Completed

Dose-Escalation and Safety Trial of YN968D1

Cancer Patients With Solid Tumors

Korea, Republic of, United States
Yang Zhijun

Unknown

Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer

Ovarian Cancer
Chinese PLA General Hospital

Unknown

The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer

Gastric Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric

Esophagus Cancer, Stage III | Esophageal Gastric Cardia Type Metaplasia | Esophagus Cancer, Stage IV

China
First Affiliated Hospital Bengbu Medical College

Unknown

Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer

Gastric Cancer | Apatinib | Biomarker

China
Zhejiang Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

Gastric Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors (HS:Hansoh;)

Advanced Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

China
Pfizer
Forest Laboratories

Completed

Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections

Complicated Intra-Abdominal Infection

United States, Croatia, Bulgaria, Peru, Russian Federation, Latvia, Ukraine, Mexico, Romania, South Africa, Argentina, Czechia, Hungary, Israel, Taiwan, India, Thailand, Spain, Netherlands, Malaysia
Beijing Friendship Hospital

Unknown

A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer

Gastric Cancer

China

Search clinical trials for: Apatinib

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations